The rise of Viagra initially sparked a period of growth for pharma, nevertheless recent developments present a murky picture for shareholders. Off-patent versions are eating into revenue, and continued patent https://steveljdv817758.activoblog.com/52287681/viagra-and-the-pharmaceutical-industry-a-risky-bet